...
...

drug controller general of india news

Drug body asks states, UTs to ensure strict testing amid cough syrup deaths

The Tamil Nadu government on Tuesday evening sealed the pharma unit that was producing the now-banned 'Coldrif' cough syrup.
india news
Updated on Oct 09, 2025 02:52 am IST

NHRC issues notices to Delhi chief secretary, others on quality of medicines

According to official documents accessed by HT, 43 samples of five drugs were picked up during a random inspection on July 24 and 25 at Delhi government’s Lok Nayak Hospital, Institute of Human Behaviour and Allied Sciences and Deen Dayal Upadhyay Hospital.
delhi news
Updated on Dec 30, 2023 01:17 am IST

Govt plans common drugs standards for all state regulators

In the past six months, there have been at least three cases of deaths reported globally that are linked to drugs exported from India.
india news
Updated on Mar 17, 2023 02:41 am IST

Biological E's ‘Corbevax’ gets DCGI approval for two clinical trials

Union health minister Mansukh Mandaviya meets Mahima Datla, MD of Biological E. Limited, in New Delhi.
india news
Published on Sept 03, 2021 03:09 pm IST

Covishield and Covaxin: What’s next after Drug Controller’s approval?

Health workers preparing for Covid-19 vaccination mock drill at Rajawadi Municipal Corporation Hospital in Mumbai.
india news
Updated on Jan 03, 2021 06:31 pm IST

Approval for Covaxin a giant leap for novel product development in India: Bharat Biotech

A medic fills a syringe with Covaxin, a government-backed experimental Covid-19 vaccine, before administering it to a health worker during its trials.
india news
Published on Jan 03, 2021 02:58 pm IST

‘Finally paid off’: Adar Poonawalla thanks PM Modi, DCGI after Covishield gets final approval

Adar Poonawalla, Chief Executive Officer (CEO) of the Serum Institute of India, thanked all stakeholders after Covishield got final nod in India.
india news
Updated on Jan 03, 2021 08:29 pm IST

Covaxin approval: All you need to know about Bharat Biotech Covid-19 vaccine’s efficacy, price

A volunteer being vaccinated by a medic during the Bharat Biotech's 'Covaxin' human trial in Jaipur.
india news
Updated on Jan 02, 2021 10:00 pm IST

Bharat Biotech’s Covaxin safe, says Phase 1 trial data

Bharat Biotech has developed the whole-virion inactivated SARS-CoV-2 vaccine candidate (BBV152) in collaboration with ICMR.
india news
Updated on Dec 17, 2020 05:47 am IST

Serum Institute seeks approval for Covid-19 vaccine; Adar Poonawalla thanks PM for support

Vials of COVISHIELD before they are packaged inside a lab at Serum Institute of India, Pune, earlier in November.
india news
Updated on Dec 07, 2020 06:49 pm IST

AIIMS to submit proposal for phase 3 trials of Covaxin next week

AIIMS plans to recruit anywhere between 2,000-5,000 participants for the upcoming phase 3 trial once they get the approval.
india news
Updated on Oct 31, 2020 03:13 am IST

Bharat Biotech to submit revised Phase 3 clinical trial protocol to DCGI by next week

Human clinical trials for Covaxin began across India in July 2020. As per the current plan, the Phase 3 trial, to determine vaccine efficacy, will begin early to mid-November this year.
health
Updated on Oct 24, 2020 08:31 am IST

India’s first Covid-19 vaccine will be at least 60% effective: Bharat Biotech

As per the current plan, the Phase 3 trial to determine vaccine efficacy will begin early to mid-November with 26,000 study subjects at 25 to 30 sites across 13-14 states.
health
Updated on Oct 23, 2020 03:07 pm IST

Data breach at Dr Reddy’s forces lab to temporarily shot operations across globe

Dr Reddy’s Laboratories had recently received approval from the drugs controller general of India to conduct an adaptive phase 2/3 clinical trial in India for Russia’s Sputnik V vaccine candidate against Coronavirus disease (Covid-19).
health
Updated on Oct 22, 2020 03:48 pm IST

Covid-19 vaccine: Sputnik V to undergo trial in India, Dr Reddy’s gets DCGI approval

Sputnik V, the first registered Covid-19 vaccine of the world, will now undergo trials in India.
india news
Updated on Oct 17, 2020 04:06 pm IST

Zydus Cadila begins human dosing in trials of Covid-19 vaccine candidate

A pharmaceutics worker shows a shot of a vaccine developed by Zydus Cadila to treat the Covid-19 coronavirus after it received approval from the Drug Controller General of India to start phase one and two of human clinical trials, in Ahmedabad.
india news
Updated on Jul 17, 2020 05:59 am IST

Bharat Biotech to start human trials for first indigenous Covid-19 vaccine from July

Human clinical trials are scheduled to start across India in July 2020.
india news
Updated on Jun 30, 2020 02:23 pm IST

The scary truth behind generic drugs in India

Our faith in Indian generic medicines is often misplaced. They frequently don’t work. Sometimes, no matter how many tablets you take, they will not treat the disease or infection
columns
Updated on Jul 13, 2019 06:58 pm IST

In injectable contraceptive, forest dept finds a solution to control monkey menace

To control the monkey menace in the city, the Delhi government’s forest department is pinning all its hopes on an injectable contraceptive, developed by an IIT Delhi professor in the 1980s, for human males.
delhi news
Published on Apr 27, 2019 06:13 am IST

ICMR questions Mumbai hospital’s stem-cell therapy

The Indian Council of Medical Research (ICMR) has called into question the ethics and protocols followed by a Santacruz-based super-speciality paediatrics hospital in its use of stem-cell therapy to treat a 26-week-old preterm baby’s lung condition.
mumbai news
Updated on Apr 26, 2019 08:27 am IST

Barcoding raw materials used in drugs to become mandatory

Image for representation
india news
Updated on Apr 21, 2019 07:51 am IST

‘Pharmacy’ to be used in place of ‘chemists & druggists’

The Drug and Technical Advisory Board (DTAB) has approved changing the Drugs and Cosmetics Rules to bring uniformity to medical store signboards.
india news
Published on Apr 19, 2019 07:27 am IST

Government awards Delhi patient ₹67 lakh for faulty J&J implant

At least 200 applications are under consideration by state-level committees for compensation from patients who received the faulty Articular Surface Replacement (ASR) hip implant in India.
delhi news
Updated on Apr 05, 2019 07:49 am IST

New clinical trial rules to fast-track access to drugs

New clinical trial rules to fast-track access to drugs
india news
Updated on Mar 26, 2019 07:18 am IST

Johnson & Johnson show-caused by DGCI over ad

Johnsons Baby Powder from Johnsons and Johnsons Product at Spencers retail store Kaushambhi in Ghaziabad. Image for representation.
india news
Updated on Mar 06, 2019 12:42 am IST

Centre approves ₹30L to ₹1.23 cr relief in faulty hip implants case

Faulty Articular Surface Replacement (ASR) hip implants, manufactured by DePuy International Limited — a subsidiary of Johnson & Johnson Pvt Ltd, were recalled in 2010 globally after complaints of more-than-usual revision surgeries due to complications such as metal leaching and infections, among others.
india news
Updated on Nov 30, 2018 12:01 am IST

Health ministry notifies new draft rules for online sale of drugs

The rules ban sale of narcotics, psychotropic drugs and tranquillizers.
health
Updated on Sept 01, 2018 09:03 pm IST

India bans import of rabies vaccine from Chinese manufacturer

Rabies kills an estimated 20,000 people in India each year, according to the National Rabies Control Programme.
india news
Published on Aug 01, 2018 12:12 am IST
View more
Home / Topic / Drug Controller General Of India / News
Sign in
Sign out
Subscribe Now
Copyright © HT Digital Streams Ltd. All rights reserved.